Augmentin Administration in Cephalosporin-Allergic Patients

Introduction to Safe Prescribing

• The Dutch SWAB guidelines recommend that patients with cephalosporin allergy can receive penicillins with dissimilar side chains, regardless of severity or time since the index reaction (strong recommendation) 1
• The American College of Clinical Microbiology and Infection suggests that cross-reactivity between beta-lactams is driven by R1 side chain similarity, not the beta-lactam ring itself 1

Understanding Cross-Reactivity

• Patients with cephalosporin allergy can receive penicillins with dissimilar side chains (strong recommendation) 1
• The cross-reactivity rates for specific combinations range from 5.3% to 14.5% 2

Specific Cephalosporins to Avoid

• Avoid amoxicillin/ampicillin (including Augmentin) ONLY if the patient is allergic to cephalexin, cefaclor, or cefamandole - these share similar R1 side chains 1, 3
• If the patient is allergic to other cephalosporins (ceftriaxone, cefazolin, cefuroxime, cefepime, ceftazidime), Augmentin can be safely administered 1, 2

Alternative Options

• Carbapenems can be used in any patient with cephalosporin allergy without prior testing (cross-reactivity only 0.87%) 3
• Aztreonam (monobactam) can be used safely, except in patients allergic to ceftazidime or cefiderocol due to shared side chains 1, 3
• Fluoroquinolones with or without clindamycin provide broad-spectrum non-beta-lactam coverage 2

Critical Pitfalls to Avoid

• Do not automatically avoid all penicillins in cephalosporin-allergic patients - this is overly cautious and denies patients effective therapy 1, 2
• The historical 10% cross-reactivity rate is a myth; actual cross-reactivity with dissimilar side chains is approximately 1-2% 2
• The clavulanate component of Augmentin is not typically the allergen - the amoxicillin component drives cross-reactivity concerns 2